Yale-CURE BioHaven Entrepreneurship Seminar Series

The Yale-CURE BioHaven Entrepreneurship Series features presentations designed to showcase regionally developed life science technologies that have progressed along the path to commercialization. Speakers at the BioHaven events represent both the scientific and business side of the enterprises. The programs focus on key success factors of each company, scientific or technological advantage, business model, and lessons learned in starting and developing the business. The series also provides social networking opportunities for scientists/researchers in the Yale/New Haven community.

Click here for more information about CURE (Connecticut United for Research Excellence).

 

2012-2013 Events: Events Flyer

Registration for all BioHaven events is free for the Yale community and employees of CURE member companies. Please RSVP in advance. E-mail to biohaven@yale.edu or call the Yale Office of Cooperative Research at (203) 785-6209. Please see the flyer for all details.

 

Jackson Laboratory for Genomic Medicine followed by a conversation with UCONN and Yale	When	Tuesday, April 30, 2013, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	Hope Building, Room 216, 315 Cedar St
	Panelists:	Edison Liu, M.D., President and CEO, The Jackson Laboratory Marc Lalande, Ph.D., Professor and Chairman of the Department of Genetics and Developmental Biology, and Associate Dean for Research Planning and Coordination at the University of Connecticut School of Medicine Haifan Lin, Ph.D., Professor of Cell Biology and of Genetics at Yale University; Director, Yale Stem Cell Center Susan Froshauer, Ph.D. (Moderator), President and CEO, CURE
The State of Connecticut has made a $291 million dollar bet that Jackson Laboratory for Genomic Medicine (JAX) will help Connecticut assume a position of global leadership in personalized medicine. By combining JAX’s strength in genetic technologies with the clinical and scientific expertise of University of Connecticut and Yale, both the State and the research community are hoping to see accelerated development of medical treatments and tests tailored to patient’s specific genetic make up.

 

Past Seminars:

 

Yale Entrepreneurial Institute (YEI) Three Recent Student-Led Start-Ups in Healthcare	When:	Tuesday, February 26, 2013, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Moderator:	James G. Boyle, Ph.D., Director, Yale Entrepreneurial Institute
For more than 6 years, The Yale Entrepreneurial Institute has helped Yale students develop entrepreneurial skills by launching businesses. Recently the program expanded to include start ups that involve Yale intellectual property and faculty. At BioHaven, students, faculty and mentors will share their experiences with YEI using real life examples of how the program has connected students to Connecticut business people -- many of whom has participated as mentors, advisors and investors.

 

C8 Sciences: Cognition Cross-Training for Children and Adults	When:	Wednesday, January 30, 2013, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speakers:	Bruce E. Wexler, M.D., Professor Emeritus of Psychiatry and Senior Research Scientist, Yale Medical School; Director of the Neurocognitive Research Laboratory, Connecticut Mental Health Center Ken Coleman, President and Co-Founder
C8 Sciences develops and markets neuroscience-based cognition assessment and development products that have the potential to solve some of the most significant problems affecting children and the aged. C8 is the only company to offer integrated computer and physical exercises - "cognition cross-training." Its products are based on proprietary research developed at Yale University by Dr. Bruce Wexler, and the company was recently awarded a prestigious $3M Director's Office Grant by the National Institutes of Health to study the use of C8Kids for treating ADHD. This grant is reserved for research programs that have the potential for a paradigm change in US healthcare.

 

Transformational US Healthcare Opportunities in the Decade Ahead	When:	Wednesday, January 23, 2013 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speaker:	Richard N. Foster, Ph.D., Senior Faculty Fellow, Yale School of Management; emeritus director, McKinsey & Company, Inc.; Managing Partner, Millbrook Management Group; Venture Partner, Lux Capital Groupneurial Institute
A senior faculty fellow at Yale School of Management, Richard N. Foster is an emeritus director of McKinsey & Company, Inc. where he was director and senior partner. While at McKinsey he founded several practices including the technology and innovation practice, the healthcare practice and the private equity practice. A best selling author, Dr. Foster's research interests are in the relationships between capital formation, innovation, and regulation. Dr. Foster has written two bestselling books: Innovation: The Attacker's Advantage (1986) and Creative Destruction (2001), as well as several dozen articles in research and popular journals.

 

Innovation and the Future of the Affordable Care Act after Election 2012	When:	Tuesday, November 13, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	Kline Geology Laboratory Auditorium, 210 Whitney Ave (Parking Lot 22)
	Panelists:	Michael Woody, partner in the Washington lobbying firm East End David Boyer, vice president of the bipartisan lobbying firm BGR Government Affairs Connecticut Biotechnology Growth Council Members Paul Pescatello (Moderator), President and CEO, CURE
Biopharma industry and legal experts analyze the recent Supreme Court decision regarding the Affordable Care Act and explain how implementation of the ACA will affect new medicine and medical device R&D and pricing, as well as life sciences innovation generally. Occurring just 10 days after the presidential election, this joint BioHaven / CURE Annual Meeting session will be a great chance to see where we are and whether adjustments need to be made to investment, business and research plans.

 

Today's Investment Landscape for Life Sciences	When:	Thursday, October 11, 2012, 5:00 pm program, 6:00 pm networking, refreshments and wine bar
	Where:	Harkness Lounge, 367 Cedar Street, New Haven
	Speaker:	Mary J. Tanner, Managing Director, Peter J. Solomon Company
A managing director in the Peter J. Solomon investment banking advisory firm, Mary Tanner co-heads with her husband Fred Frank the company's global pharmaceutical and life science practice. Mary has devoted more than 25 years to the global healthcare industry and counts among her many clients and accomplishments: Pfizer in its $60B acquisition of Pharmacia; Amgen in its $16B acquisition of Immunex; Rhone-Poulenc in its acquisition of Rorer; then Rhone-Poulenc Rorer in its acquisition of UK company Fisons; BASF/BASF Pharma, a German company, in its acquisition of UK company Boots Pharmaceuticals. She serves on the Dean's Council of the Yale Medical School and the Yale University Council on Technology Transfer.

 

Chondrogenics, Inc.	When:	Thursday, April 26, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speakers:	Caroline Dealy, Ph.D., Scientific Founder and Associate Professor, Center for Regenerative Medicine and Skeletal Development, UConn Health Center James Heym, Ph.D., Senior Director of Life Science Ventures, UConn R&D Corp.
	Archive:	Video
Chondrogenics, Inc. is developing stem cell therapy for the treatment of osteoarthritis and the repair of damaged cartilage associated with diseased and damaged joints. Dr. Dealy and colleagues have developed a novel process for producing substantially homogeneous populations of chondrogenic cells and earlier progenitor cells from stem cells, including induced pluripotent stem cells.

 

Soft Tissue Regeneration, Inc.	When:	Thursday, March 29, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speaker: Archive:	Joseph Reilly, President and CEO Video
Soft Tissue Regeneration, Inc. (STR) is an early-stage orthopaedic device company developing a breakthrough, tissue engineering platform used to regrow ligaments and tendons. STR’s first product, the L-C Ligament® is a ready to use, biocompatible and biodegradable synthetic scaffold that facilitates re-growth of a patient’s anterior cruciate ligament (ACL) within the knee – providing joint stabilization and ultimately resulting in faster, better healing and greater odds of making a full recovery. The Company’s proprietary and patented technology utilizes and FDA-approved degradable polymer. more »

 

Personalized Medicine: How Far Off?	When:	Tuessday, February 28, 2012, 4:30 pm registration, 5:00 pm program, 6:00 pm networking, refreshments and wine bar
	Where:	Harkness Auditorium (NOTE LOCATION CHANGE)
	Panelists:	Richard Lifton, M.D., Ph.D., Sterling Professor of Genetics and Professor of Medicine (Nephrology), Yale University; Chair, Department of Genetics Thomas Lynch, M.D., Director, Smilow Cancer Center at YNHH Jonathan Rothberg, Ph.D. , Founder, CEO and Chairman, Ion Torrent Systems, Life Technologies Timothy Shannon, M.D., Partner, Canaan Partners Paul Pescatello (Moderator), President and CEO, CURE
	Archive:	Video
Genomic technologies have opened the door to medicine that takes into account the unique clinical, genetic, genomic and environmental characteristics of individuals. This session will explore the state of personalized medicine today, its application both scientifically and in the clinic and commercial opportunities and challenges in the near and mid-term.

 

Thetis Pharmaceuticals, Inc.	When:	Wednesday, January 25, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speakers:	Gary Mathias, Chief Financial Officer Frank Sciavolino, Ph.D., Chief Scientific Officer and Co-founder
	Archive:	Video
Thetis Pharmaceuticals is a drug development company that is advancing TP101, a novel, first-line therapy for type 2 diabetes. TP101 is a new molecular entity that chemically combines metformin, the standard of care in type 2 diabetes, with the principal component from omega-3 polyunsaturated fatty acids. TP101 uniquely targets both glycemic and lipid control in diabetes patients and, for the first time, offers prospects for addressing the high incidence of cardiovascular complications, a major risk factor in type 2 diabetic and pre-diabetic patients. The company expects to begin clinical studies with TP101 in 2012.

 

Healthcare IT: Challenges and Opportunities	When:	Tuesday, November 15, 2011, 4:30 pm registration, 5:00 pm program, 6:00 pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Panelists:	David Jahnes, Managing Partner, Galen Partners James Staten, Executive VP, Corporate and Financial Services, YNHHS and CFO and Senior VP for Finance, Yale-New Haven Hospital Matt Walton, CEO, MyCare LLC
Health IT is a booming field. Document management for Electronic Health Records and demands for mobility while ensuring the security of medical records are major concerns for providers. Entrepreneurs are navigating a regulatory environment that is more complex than ever before while racing to implement the connectivity required for Healthcare Information Exchanges. How are providers incorporating clinical decision support into practices? Where are investors putting their money? An all-star panel of a hospitalist, a regulatory expert, an investor and entrepreneur talk about where Health IT is trending.

 

Axerion   Therapeutics	When:	Wednesday, March 2, 2011, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speaker:	Sylvia McBrinn President and Chief Executive Officer; Stephen Strittmatter, M.D. Ph.D.; Vincent Coates Professor of Neurology, Yale University Professor of Neurobiology, Yale University
	Archive:	Video

 

	When:	Wednesday, February 16, 2011, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speaker:	Eleanor Trandler President and CEO; Kurt Roberts, M.D. Assistant Professor of Surgery, Yale University
	Archive:	Video

 

	When:	Wednesday, January 19, 2011, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
	Where:	The Anlyan Center
	Speaker:	Martin L. Verhoef, President ; Frank Slack, Ph.D. Associate Professor, Department of Molecular, Cellular and Developmental Biology, Yale University
	Archive:	Video

 

	When:	Thursday, November 18, 2010, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
	Where:	Yale Epidemiology & Public Health Building (LEPH), 1st Floor, Winslow Auditorium, 60 College Street (corner of South Frontage Road), New Haven (NOTE LOCATION CHANGE)
	Speaker:	Solomon S. Steiner, Ph.D. Chief Scientific Officer and Co-Founder; Erroll De Souza, Ph.D. President and CEO
	Archive:	Video

 

	When:	Wednesday, October 27, 2010, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
	Where:	Hope Auditorium
	Speaker:	Seth Feuerstein, M.D., J.D. Cobalt Therapeutics
	Archive:	Video

 

	When:	Thursday, September 16, 2010, 6:00pm seminar, 7:00pm networking, refreshments and wine bar
	Where:	Hope auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Alfred E. Mann has founded and largely funded 17 companies in his career. Nine were acquired at an overall total of almost $8 billion, and two became public companies. He is currently chairman and EO of Mannkind Corporation.
	Archive:	Video

 

 

 

 

 

 

 

 

	When:	Wednesday, May 26, 2010
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Arthur G. Altschul, Jr., Co-Founder and Chairman of the Board; Joseph Schlessinger, Ph.D., Co-Founder, Director and Scientific Advisory Board Chairman and Michael Schmertzler, Chief Executive Officer

Archive:

Video

 

	When:	Wednesday, May 12, 2010
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Alidad Mireskandari, President & CEO and Jeff Gruen, M.D., Co-founder of JS Genetics, Scientific Advisory Board Chairman

Archive:

Video

 

	When:	Thursday, April 8, 2010
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Paresh Soni, M.D., PhD, Senior Vice President and Head of Development

Archive:

Video

 

Jonathan Rothberg	When:	Wednesday, March 31, 2010
	Where:	110 Hope Memorial Building, 315 Cedar Street
	Speaker:	Jonathan Rothberg, Founder of 454 Life Sciences, CuraGen, Clarifi Corporation, The Rothberg Institute of Childhood Diseases, Ion Torrent Systems, Founder and chair, RainDance Technologies

 

Arbor Fuel	When:	Thursday, February 25, 2010
	Where:	Yale University, Kline Geology Lab Building, 210 Whitney Ave, New Haven
	Speaker:	Steven Henck, President & CEO

 

 

Advanced Orthopedic Technologies & CardioPhotonics	When:	Thursday, January 28, 2010
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Thomas Wood, President & CEO; John S. Reach, M.Sc., M.D.; Kirk Shelley, M.D., Ph.D.
	Archive:	Video

 

	When:	Wednesday, November 18, 2009
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Joseph Catino, Ph.D.; Peter M. Glazer, M.D., Ph.D.

 

	When:	Wednesday, October 21, 2009
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speaker:	Derek Chalmers, Ph.D., D.Sc, President & CEO

 

 

	When:	Wednesday, May 6, 2009
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Michael Sherman, President, and Michael Weiner, Vice President of Molecular Sciences
	Archive:	Broadband | Modem (RealPlayer required)

 

	When:	Wednesday, March 25, 2009
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	John Hambor, Ph.D., Chief Executive Officer, CellDesign and Linda Powers, Co-Founder and Managing Director, Toucan Capital, Inc.
	Archive:	Powerpoint
	Archive:	Broadband (RealPlayer required)

 

	When:	Thursday, March 5, 2009
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Seth Feuerstein MD JD, President; W. Mark Saltzman PhD. Scientific Advisor and Tarek Fahmy PhD. Scientific Advisor
	Archive:	Broadband (RealPlayer required)

 

Unexpected Outcomes: Navigating Scientific & Management Land Mines	When:	Thursday, November 13, 2008
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Michael Kishbauch, Ph.D., President & CEO, Achillion Pharmaceuticals Inc.; Tom Wood, Founding CEO, Applied Spine Technologies; Ron Lennox, D. Phil., Partner, CHL Medical Parnters
		More info...

 

	When:	Thursday, October 16, 2008
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Geoffrey Erickson, Ph.D., President & CEO, Humacyte, Inc. Laura Niklason, M.D., Ph.D., Founder & CSO, Humacyte, Inc., Associate Professor of Anesthesia & Biomedical Engineering, Yale University
		More info...

 

	When:	March 19, 2008
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Colin Foster, President and Chief Executive Office, Optherion Amanda Hayward, Ph.D., Senior Vice President, Scheer & Company, Inc.
		More info...

	When:	April 16, 2008
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Roger Longman, Managing Partner, Windhover Information Inc.(moderator) William Burkoth, Senior Manager, Pfizer’s Venture Investments Group, Pfi zer Inc. Richard Flavell, Ph.D., Professor and Chairman of Immunobiology; Professor of Molecular, Cellular & Developmental Biology, Yale University; Investigator, Howard Hughes Medical Institute Haifan Lin, Ph.D., Professor of Cell Biology; Director, Yale Stem Cell Center David Scheer, President, Scheer & Company, Inc.
		More info...

	When:	April 23, 2008
	Where:	The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
	Speakers:	Ben Bronstein, M.D., Co-founder; President/ COO, Vidas Ocular Bruce Shields, M.D., Marvin L. Sears Professor and Chairman Emeritus, Department of Opthamology and Visual Science, Yale University School of Medicine; Co-Founder; Chief Scientific and Medical Officer, Vidus Ocular
		More info...

 

	When:	February 12, 2008
	Speakers:	Susan Froshauer, Ph.D. President and CEO, Rib-X
	Archive:	Broadband | Modem (RealPlayer required)
		More info...

More information... (pdf)	When:	November 13, 2007
	Speakers:	John P. Marano, Jr., Ph.D., Co-Founder, President & CEO, Vascular Insights LLC Michael Tal, M.D., Associate Professor of Radiology, Yale School of Medicine; Co-Founder, and Chief Medical Advisor, Vascular Insights LLC
	Archive:	PowerPoint
	Video:	Broadband | Modem (RealPlayer required)
		More info...

	When:	October 24, 2007
	Speakers:	Ronald W. Lennox, D. Phil. Partner, CHL Medical Partners and Interim CEO, BioRelix Pharmaceuticals, Inc. Ronald Breaker, Ph.D. Henry Ford II Professor in the Department of Molecular, Cellular and Developmental Biology, Yale University; Investigator, Howard Hughes Medical Institute
	Video:	Broadband | Modem (RealPlayer required)
		More info...

	When:	January 17, 2007
	Speakers:	Peter Fuller, Ph.D., Chief Operating Officer, CGI Pharmaceuticals, Inc. Ira Mellman, Ph.D., Yale University Sterling Professor of Cell Biology & Immunology; Founder & Scientific Advisor, CGI Pharmaceuticals, Inc.
	Video:	Broadband | Modem (RealPlayer required)